Topic: Aesthetic Nurse

There is renewed political discussion regarding a potential ban on direct-to-consumer pharmaceutical advertising, a practice currently legal only in the U.S. and New Zealand. Critics argue that the 1997 rule change allowing these ads has led to "agency capture" of the media and increased drug consumption. Meanwhile, the "aesthetic nurse" industry continues to thrive, with specialists providing mobile injections of fillers and metabolic drugs to a growing market.

Listeners clarified the role of a "nurse injector," a term used for medical professionals certified to administer Botox and fillers. The "aesthetic nurse injector" featured in recent media was likely an expert in cosmetic procedures rather than a general health expert. This context explains her warnings against "black market" GLP-1 weight loss drugs, as many aesthetic offices now offer semaglutide as a side service.